Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-09

Clinical Trial Update: Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus [NA]

View source ↗

Summary

A completed clinical trial comparing intravenous brivaracetam to intravenous levetiracetam for the management of status epilepticus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)
  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Muhammad Aamir Latif | Conditions: Status Epilepticus | NA | Status: COMPLETED